VolitionRX Ltd
ASE:VNRX 3:51:45 PM EDT
| Market Cap (Intraday) | 50.88M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.67 |
| 50-Day MA | $0.89 |
| 200-Day MA | $0.96 |
VolitionRX Ltd Stock, ASE:VNRX
1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014
United States of America
Phone: +1.646.650.1351
Number of Employees: 110
Description
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.